GV 2019, L.P.
- SEC CIK
- 0001845041
In the past year, 7 open-market sale filings worth $50.2M and no purchases.
Current role at each company
- LIFE Ethos Technologies Inc.10% Owneras of Jul 29, 2026
- VERV Verve Therapeutics, Inc.10% Owneras of Jul 28, 2025
- PRME Prime Medicine, Inc.10% Owneras of Jun 22, 2023
- IONQ IonQ, Inc.Other: Former 10% Group Memberas of Apr 12, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $50.2M
- 7 filings
- Net
- −$50.2M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists GV 2019, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LIFE Ethos Technologies Inc.
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 (view filing)6:43 PM ET | Jan 30 | Same day | Alphabet Inc. and 9 others10% Owner | SSaleClass A Common Stock | −1.85M | $19.00 | −$35.1M | −36.6%3.20M after | 2 lots |
| May 18, 2026 (view filing)6:43 PM ET | May 14-15 | 4 days | Alphabet Inc. and 6 others10% Owner | SSaleClass A Common Stock | −147.6K | $23.45 | −$3.46M | −100.0%0 after | 3 lots |
| Jul 17, 2026 (view filing)8:12 PM ET | Jul 15-16 | 2 days | Alphabet Inc. and 6 others10% Owner | SSaleClass A Common Stock | −94.1K | $19.47 | −$1.83M | −100.0%0 after | 3 lots |
| Jul 21, 2026 (view filing)5:11 PM ET | Jul 17-20 | 4 days | Alphabet Inc. and 6 others10% Owner | SSaleClass A Common Stock | −38.9K | $18.77 | −$730.5K | −100.0%0 after | 2 lots |
| Jul 23, 2026 (view filing)4:47 PM ET | Jul 21-22 | 2 days | Alphabet Inc. and 6 others10% Owner | SSaleClass A Common Stock | −72.5K | $19.17 | −$1.39M | −100.0%0 after | 3 lots |
| Jul 27, 2026 (view filing)6:21 PM ET | Jul 23-24 | 4 days | Alphabet Inc. and 6 others10% Owner | SSaleClass A Common Stock | −86.7K | $19.01 | −$1.65M | −100.0%0 after | 2 lots |
| Jul 29, 2026 (view filing)7:28 PM ET | Jul 27-28 | 2 days | Alphabet Inc. and 6 others10% Owner | SSaleClass A Common Stock | −315.1K | $19.25 | −$6.07M | −100.0%0 after | 2 lots |
PRME Prime Medicine, Inc.
10% Owner16 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 (view filing)8:02 PM ET | Oct 24 | 2 days | Alphabet Inc. and 6 othersOther: Member of a 10% Group | PPurchase | +800.0K | $17.00 | +$13.6M | +7.5%11.5M after | |
| May 10, 2023 (view filing)4:17 PM ET | May 8-9 | 2 days | Alphabet Inc. and 6 others10% Owner | SSale | −422.0K | $14.09 | −$5.95M | −3.7%11.1M after | 2 lots10b5-1 |
| May 12, 2023 (view filing)4:16 PM ET | May 10-11 | 2 days | Alphabet Inc. and 6 others10% Owner | SSale | −114.0K | $13.82 | −$1.58M | −1.0%11.0M after | 3 lots10b5-1 |
| May 16, 2023 (view filing)4:16 PM ET | May 12-15 | 4 days | Alphabet Inc. and 6 others10% Owner | SSale | −185.2K | $12.74 | −$2.36M | −1.7%10.8M after | 2 lots10b5-1 |
| May 18, 2023 (view filing)4:16 PM ET | May 16-17 | 2 days | Alphabet Inc. and 6 others10% Owner | SSale | −65.6K | $12.63 | −$829.3K | −0.6%10.7M after | 2 lots10b5-1 |
| May 22, 2023 (view filing)4:21 PM ET | May 18-19 | 4 days | Alphabet Inc. and 6 others10% Owner | SSale | −90.3K | $13.62 | −$1.23M | −100.0%0 after | 3 lots10b5-1 |
| May 24, 2023 (view filing)5:07 PM ET | May 22-23 | 2 days | Alphabet Inc. and 6 others10% Owner | SSale | −131.9K | $14.33 | −$1.89M | −100.0%0 after | 2 lots10b5-1 |
| May 26, 2023 (view filing)4:17 PM ET | May 24-25 | 2 days | Alphabet Inc. and 6 others10% Owner | SSale | −31.1K | $13.45 | −$417.9K | −100.0%0 after | 2 lots10b5-1 |
| May 31, 2023 (view filing)4:15 PM ET | May 26-30 | 5 days | Alphabet Inc. and 6 others10% Owner | SSale | −29.4K | $13.70 | −$402.8K | −100.0%0 after | 2 lots10b5-1 |
| Jun 2, 2023 (view filing)4:17 PM ET | May 31-Jun 1 | 2 days | Alphabet Inc. and 6 others10% Owner | SSale | −61.9K | $14.17 | −$876.2K | −100.0%0 after | 3 lots10b5-1 |
VERV Verve Therapeutics, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 (view filing)4:25 PM ET | Oct 31-Nov 1 | 2 days | Alphabet Inc. and 6 othersOther: Member of 10% Group | SSale | −171.3K | $37.95 | −$6.50M | −3.8%4.39M after | 14 lots |
| Nov 4, 2022 (view filing)4:16 PM ET | Nov 2-3 | 2 days | Alphabet Inc. and 6 othersOther: Member of 10% Group | SSale | −156.4K | $33.95 | −$5.31M | −3.5%4.31M after | 12 lots |
| Nov 8, 2022 (view filing)5:04 PM ET | Nov 4 | 4 days | Alphabet Inc. and 6 othersOther: Member of 10% Group | SSale | −97.2K | $31.14 | −$3.03M | −2.2%4.26M after | 6 lots |